Voyager Therapeutics Inc

VYGRNASDAQ · USD
3.09USD0.00 (+1.65%)
325

Voyager Therapeutics Inc (VYGR) Option Chain

As of September 18, 2026, Voyager Therapeutics Inc is trading at $3.09, a +1.65% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 243.7%. IV Rank is 44%.

Read more

Tracking the VYGR option chain helps you see every strike and expiry on Voyager Therapeutics Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Voyager Therapeutics Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of VYGR options activity at a glance. Use our scanner to monitor the VYGR option chain in real time and filter for the VYGR options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For VYGR stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the VYGR option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where VYGR stock options are being actively traded and where they are not.

Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyotrophic lateral sclerosis; VY-HTT01 for Huntington's disease; VY-FXN01 for Friedreich's ataxia; and Tau program for the treatment of tauopathies, including Alzheimer's disease, progressive supranuclear palsy, and frontotemporal dementia, as well as for spinal muscular atrophy.

The company has collaboration and license agreements with Neurocrine Biosciences, Inc., Pfizer Inc., and Novartis Pharma, A.G. for the research, development, and commercialization of adeno-associated virus gene therapy products. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Voyager Therapeutics Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen VYGR options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of VYGR stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile48.41% Neutral
  • Market cap (M$)190
  • 52 weeks high-44.32%
  • 52 weeks low5.10%
  • Analyst recommendationStrong Buy
    1.09
  • Target price$14.89
    381.88% above the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-11-09
  • P/E
  • Future P/E
  • EPS (ttm)-1.81
  • EPS growth next 5 years15.26%

As of September 18, 2026

2026-10-16
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
0.00600.562.090.305.001.00-67.113.800.003.8001100.00
0.00303.811.094.902.00-34.210.050.000.0503100.00
44.671,05814.310.094.403.00-1.321.000.001.00019555.33
99.8884610.180.000.100.254.00+31.584.900.913.990430.12
100.001,56600.300.000.305.00+64.470.205.001.910.690360.00

As of September 18, 2026

Scan the full option chain in one place

Browse the full VYGR option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial